Ronald Kiguba

1.3k total citations
41 papers, 498 citations indexed

About

Ronald Kiguba is a scholar working on Toxicology, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ronald Kiguba has authored 41 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Toxicology, 14 papers in Infectious Diseases and 13 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ronald Kiguba's work include Pharmacovigilance and Adverse Drug Reactions (16 papers), HIV/AIDS drug development and treatment (9 papers) and Pharmaceutical studies and practices (9 papers). Ronald Kiguba is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (16 papers), HIV/AIDS drug development and treatment (9 papers) and Pharmaceutical studies and practices (9 papers). Ronald Kiguba collaborates with scholars based in Uganda, United Kingdom and United States. Ronald Kiguba's co-authors include Sheila M. Bird, Charles Karamagi, Sten Olsson, Catriona Waitt, Paul Waako, Elly Katabira, Charles Karamagi, Jayne Byakika-Tusiime, Francis Ssali and Peter Mugyenyi and has published in prestigious journals such as PLoS ONE, Journal of Antimicrobial Chemotherapy and British Journal of Clinical Pharmacology.

In The Last Decade

Ronald Kiguba

40 papers receiving 485 citations

Peers

Ronald Kiguba
Marc Blockman South Africa
J.M. Verzijl Netherlands
Daniel Yilma Ethiopia
Ushma Mehta South Africa
Wubshet Tesfaye Australia
Marc Blockman South Africa
Ronald Kiguba
Citations per year, relative to Ronald Kiguba Ronald Kiguba (= 1×) peers Marc Blockman

Countries citing papers authored by Ronald Kiguba

Since Specialization
Citations

This map shows the geographic impact of Ronald Kiguba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Kiguba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Kiguba more than expected).

Fields of papers citing papers by Ronald Kiguba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald Kiguba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Kiguba. The network helps show where Ronald Kiguba may publish in the future.

Co-authorship network of co-authors of Ronald Kiguba

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Kiguba. A scholar is included among the top collaborators of Ronald Kiguba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Kiguba. Ronald Kiguba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nankabirwa, Joaniter I., Freddy Eric Kitutu, Ronald Ssenyonga, et al.. (2024). Dyslipidemia among adult people living with HIV on dolutegravir – based antiretroviral therapy at a private tertiary hospital in Kampala, Uganda: burden and determinants. BMC Infectious Diseases. 24(1). 53–53. 10 indexed citations
3.
Castelnuovo, Barbara, Nele Brusselaers, Robert C. Bollinger, et al.. (2023). Dolutegravir use over 48 weeks is not associated with worsening insulin resistance and pancreatic beta cell function in a cohort of HIV-infected Ugandan adults. AIDS Research and Therapy. 20(1). 65–65. 3 indexed citations
6.
Zakumumpa, Henry, et al.. (2022). Patient experiences of sexual dysfunction after transition to dolutegravir-based HIV treatment in mid-Western Uganda: a qualitative study. BMC Infectious Diseases. 22(1). 692–692. 5 indexed citations
10.
Kiguba, Ronald, Jackson Mukonzo, Sten Olsson, et al.. (2020). Healthcare professionals’ perspective can guide post-marketing surveillance of artemisinin-based combination therapy in Uganda. Malaria Journal. 19(1). 63–63. 2 indexed citations
11.
Kiguba, Ronald, Charles Karamagi, & Sheila M. Bird. (2017). Incidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: a prospective cohort of Ugandan inpatients. BMJ Open. 7(1). e010568–e010568. 33 indexed citations
12.
Kiguba, Ronald, Charles Karamagi, & Sheila M. Bird. (2017). Antibiotic-associated suspected adverse drug reactions among hospitalized patients in Uganda: a prospective cohort study. Pharmacology Research & Perspectives. 5(2). e00298–e00298. 15 indexed citations
13.
Kiguba, Ronald, et al.. (2015). Medication Error Disclosure and Attitudes to Reporting by Healthcare Professionals in a Sub-Saharan African Setting: A Survey in Uganda. Drugs - Real World Outcomes. 2(3). 273–287. 12 indexed citations
14.
Kiguba, Ronald, et al.. (2015). Rare, Serious, and Comprehensively Described Suspected Adverse Drug Reactions Reported by Surveyed Healthcare Professionals in Uganda. PLoS ONE. 10(4). e0123974–e0123974. 4 indexed citations
15.
Kiguba, Ronald, et al.. (2014). Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants. BMJ Open. 4(11). e005869–e005869. 34 indexed citations
16.
Kiguba, Ronald, Joseph Kabanda, Jackson Mukonzo, et al.. (2013). Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans. HIV/AIDS - Research and Palliative Care. 5. 309–309. 9 indexed citations
17.
Kalyesubula, Robert, et al.. (2011). Hepatotoxicity from first line antiretroviral therapy: an experience from a resource limited setting.. PubMed. 11(1). 16–23. 34 indexed citations
18.
Eriksen, Jaran, Fred Makumbi, Ronald Kiguba, et al.. (2011). Pharmacokinetics of the nonnucleoside reverse transcriptase inhibitor efavirenz among HIV‐infected Ugandans. HIV Medicine. 13(4). 193–201. 9 indexed citations
20.
Kiguba, Ronald, Jayne Byakika-Tusiime, Charles Karamagi, et al.. (2007). Discontinuation and Modification of Highly Active Antiretroviral Therapy in HIV-Infected Ugandans. JAIDS Journal of Acquired Immune Deficiency Syndromes. 45(2). 218–223. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026